← Leaderboards
Sarah A. Moore
University Of Missouri-Columbia
$718,853
Attributed
$955,186
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $276.4K · FY2018–21$500K$375K$250K$125K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$955,186 · 2
By mechanism
R21$955,186 · 2
Top collaborators
- Joan Ripley Coates2 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Joan Ripley Coates$645,522
- Martin L Katz$6,047,835
- Qi Zhang$7,142,056
- David J Schulz$831,199
- Jia Li$3,652,525
Others in their field
Other Emerging Leaders on “Communities”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$274,807,335
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- John E West · University Of Texas At Austin$130,233,001
- Leonard Freedman · Leidos Biomedical Research, Inc.$98,171,500
Research focus
CommunitiesPre-ClinicalResourcesResearch PersonnelTranslationsSiteDrug DevelopmentInstitutionPerformanceProceduresStandardizationTherapeutic DevelopmentAnimal Disease ModelsTrial DesignAnimal ModelDisease ModelHealth AllianceHuman ModelNovel TherapeuticsClinical TrialsInfrastructureCatalystCanis FamiliarisBiological Markers
Grant awards (4)
SMART IACUC: A path to harmonized veterinary multi-site trial review$242,000
R21 · FY2021 · TR · contact PI
SMART IACUC: A path to harmonized veterinary multi-site trial review$240,520
R21 · FY2020 · TR · contact PI
A platform trial design to accelerate translational therapies in a canine disease model of ALS$196,284
R21 · FY2019 · TR
A platform trial design to accelerate translational therapies in a canine disease model of ALS$276,382
R21 · FY2018 · TR